Trial Profile
Study of [18F]-Florbetapir in Parkinson's disease Dementia (PDD) patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2018
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Dementia; Parkinson's disease
- Focus Diagnostic use
- 27 Nov 2018 New trial record
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders